# Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy

> **NCT01935622** · PHASE2 · TERMINATED · sponsor: **Virginia Commonwealth University** · enrollment: 10 (actual)

## Conditions studied

- Non-ischemic Cardiomyopathy
- Systolic Heart Failure (NYHA II-III)

## Interventions

- **DRUG:** Doxycycline
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01935622
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** End of funding
- **Last updated:** 2014-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01935622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01935622, "Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01935622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*